Dr. Kah Fei Wan, PhD

Head of Antibody Technology at Experimental Drug Development Centre

Speaker

Pharmaceutical professional with more than 15 years of drug discovery experience in public and private sectors. Skilled in translational research, project leadership, and managing multi-functional teams in high-throughput lead discovery, antibody and protein engineering. Disease expertise spans oncology, immuno-oncology, ophthalmology, and infectious diseases. Proven success in out-licensing biologics, including a €100M+ deal with a multinational pharma. Contributed to advancing a small molecule and an ADC into Phase 1 trials, and four lead candidates into preclinical development. Combines scientific and business acumen in asset evaluation, licensing, and partnerships, driving innovation and collaborations across diverse therapeutic areas.